Back to Business

Revolution Medicines in the spotlight for earnings post-trial win

Business May 6, 2026 at 7:24 PM

Revolution Medicines in the spotlight for earnings post-trial win

Investing.com

Read at Investing.com

More Stories

BBB Foods reports first quarter 2026 results with revenue growth and net loss

BBB Foods reports first quarter 2026 results with revenue growth and net loss

🇺🇸 Investing.com 6m ago

Diversified Energy acquires Oklahoma assets for $1.18 billion

Diversified Energy acquires Oklahoma assets for $1.18 billion

🇺🇸 Investing.com 7m ago

Macerich acquires Annapolis Mall for $260 million

Macerich acquires Annapolis Mall for $260 million

🇺🇸 Investing.com 7m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play